可穿戴技术对心力衰竭管理的影响
Negar Jafari1, Sahar Yousefi Ghalati2, Venus Shahabi Raberi3
1Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Galen medical journal
|November 1, 2024
概括
可穿戴技术显示出通过持续监测和个性化护理来管理心力衰竭 (HF) 的前景. 需要进一步验证和整合才能在临床上得到广泛采用.
科学领域:
- 生物医学工程 生物医学工程
- 心脏病学 心脏病学
- 数字健康数字健康
背景情况:
- 由于其慢性和渐进性质,心力衰竭 (HF) 的管理具有挑战性.
- 可穿戴技术为持续监测,早期检测和个性化高频率护理提供了潜力.
- 将技术整合到临床工作流程中,带来了机遇和挑战.
研究的目的:
- 批判性地评估可穿戴技术对心力衰竭管理的影响.
- 对用于高频监测和临床整合的可穿戴设备的当前研究进行审查.
主要方法:
- 2010年至2024年间发表的研究的叙述性系统综述.
- 搜索了PubMed,科学网和Cochrane图书馆的相关临床试验.
- 包括用于HF管理的可穿戴设备的研究,以及关于临床工作流集成的数据.
主要成果:
- 九项研究评估了各种可穿戴技术,从健身追踪器到专用传感器.
- 可穿戴设备显示出持续健康监测的潜力,使早期干预和个性化护理成为可能.
- 挑战包括数据准确性,患者遵守,小样本大小和临床整合.
结论:
- 可穿戴技术对于心力衰竭管理越来越重要,提供可操作的见解.
- 进一步验证,设备优化和数据标准化对于常规临床实践至关重要.
- 未来的重点应该是准确性,坚持性,安全性和公平地获得可穿戴技术.
更多相关视频
相关概念视频
Pulse rhythm
768
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
768
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Holter Monitor: 24-Hour Monitoring
3
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
3
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3


